SEARCH

SEARCH BY CITATION

References

  • 1
    Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 2006; 368(9532): 312322.
  • 2
    Worrall G. Bronchiolitis. Can Fam Physician 2008; 54(5): 742743.
  • 3
    Wright AL, Taussig LM, Ray CG, Harrison HR, Holberg CJ. The Tucson Children's Respiratory Study II: lower respiratory tract illness in the first year of life. Am J Epidemiol 1989; 129: 12321246.
  • 4
    Chernick V, Kendig EL. Kendig's disorders of the respiratory tract in children. Philadelphia, PA: Saunders/Elsevier; 2006.
  • 5
    Zorc JJ, Hall CB. Bronchiolitis: recent evidence on diagnosis and management. Pediatrics 2010; 125(2): 342349.
  • 6
    Fitzgerald DA, Kilham HA. Bronchiolitis: assessment and evidence-based management. Med J Aust 2004; 180(8): 399404.
  • 7
    Coffin SE. Bronchiolitis: in-patient focus. Pediatr Clin North Am 2005; 52(4): 104757.
  • 8
    Scarfone RJ. Controversies in the treatment of bronchiolitis. Curr Opin Pediatr 2005; 17: 6266.
  • 9
    Scottish Intercollegiate Guidelines Network (SIGN). Bronchiolitis in children: a national clinical guideline. Edinburgh (Scotland); 2006; Report No.: 91.
  • 10
    Fischer GB, Teper A, Colom AJ. Acute viral bronchiolitis and its sequelae in developing countries. Paediatr Respir Rev 2002; 3(4): 298302.
  • 11
    Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 1999; 282(15): 14401446.
  • 12
    Yanney M, Vyas H. The treatment of bronchiolitis. Arch Dis Child 2008; 93(9): 793798.
  • 13
    Kusel MM, de Klerk NH, Holt PG, Kebadze T, Johnston SL, Sly PD. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J 2006; 25(8): 680686.
  • 14
    Mansbach JM, McAdam AJ, Clark S, Hain PD, Flood RG, Acholonu U. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med 2008; 15(2): 111118.
  • 15
    Everard M. Acute bronchiolitis and croup. Pediatr Clin North Am 2009; 56: 119.
  • 16
    Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010; 375: 15451555.
  • 17
    Mansbach JM, Pelletier AJ, Camargo CA, Jr. US outpatient office visits for bronchiolitis, 1993–2004. Ambul Pediatr 2007; 7: 304307.
  • 18
    Robbins JM, Kotagal UR, Kini NM, Mason WH, Parker JG, Kirschbaum MS. At-home recovery following hospitalization for bronchiolitis. Ambul Pediatr 2006; 6: 814.
  • 19
    Mansbach JM, Emond JA, Camargo CA, Jr. Bronchiolitis in US emergency departments 1992 to 2000: epidemiology and practice variation. Pediatr Emerg Care 2005; 21(4): 242247.
  • 20
    Koehoorn M, Karr CJ, Demers PA, Lencar C, Tamburic L, Brauer M. Descriptive epidemiological features of bronchiolitis in a population-based cohort. Pediatrics 2008; 122(6): 11961203.
  • 21
    Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child 2003; 88(12): 10651069.
  • 22
    Damore D, Mansbach JM, Clark S, Ramundo M, Camargo CA, Jr. Prospective multicenter bronchiolitis study: predicting intensive care unit admissions. Acad Emerg Med 2008; 15(10): 887894.
  • 23
    Spencer N, Logan S, Scholey S, Gentle S. Deprivation and bronchiolitis. Arch Dis Child 1996; 74(1): 5052.
  • 24
    Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus ME, Suffin SC, et al. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986; 315(2): 7781.
  • 25
    Purcell K, Fergie J. Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Pediatr Infect Dis J 2004; 23(5): 418423.
  • 26
    Simoes EA, Carbonell-Estrany X. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J 2003; 22(2 Suppl): S13S18.
  • 27
    Figueras-Aloy J, Carbonell-Estrany X, Quero-Jimenez J, Fernandez-Colomer B, Guzman-Cabanas J, Echaniz-Urcelay I. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatr Infect Dis J 2008; 27: 788793.
  • 28
    Holman RC, Shay DK, Curns AT, Lingappa JR, Anderson LJ. Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J 2003; 22(6): 483490.
  • 29
    Simoes EA. Maternal smoking, asthma, and bronchiolitis: clear-cut association or equivocal evidence? Pediatrics 2007; 119: 12101212.
  • 30
    Amanatidou V, Apostolakis S, Spandidos DA. Genetic diversity of the host and severe respiratory syncytial virus-induced lower respiratory tract infection. Pediatr Infect Dis J 2009; 28: 135140.
  • 31
    Miyairi I, DeVincenzo JP. Human genetic factors and respiratory syncytial virus disease severity. Clin Microbiol Rev 2008; 21: 686703.
  • 32
    Sly PD, Kusel MM, Holt PG. Do early-life viral infections cause asthma? J Allergy Clin Immunol 2010; 125: 12021205.
  • 33
    Gruber WC. Bronchiolitis: epidemiology, treatment, and prevention. Semin Pediatr Infect Dis 1995; 6(3): 128134.
  • 34
    Wennergren G. Prediction of outcome after wheezing in infancy. Acta Paediatr 2001; 90(8): 840842.
  • 35
    Korppi M. Are responses to treatment virus-specific in wheezing children? J Allergy Clin Immunol 2008; 119(6): 15611562.
  • 36
    Martinez FD. Heterogeneity of the association between lower respiratory illness in infancy and subsequent asthma. Proc Am Thorac Soc 2005; 2: 157161.
  • 37
    Perez-Yarza EG, Moreno A, Lazaro P, Mejias A, Ramilo O. The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature. Pediatr Infect Dis J 2007; 26: 733739.
  • 38
    Singh AM, Moore PE, Gern JE, Lemanske RF Jr, Hartert TV. Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation. Am J Respir Crit Care Med 2007; 175: 108119.
  • 39
    Babl FE, Sheriff N, Neutze J, Borland M, Oakley E. Bronchiolitis management in pediatric emergency departments in Australia and New Zealand: a PREDICT study. Pediatr Emerg Care 2008; 24(10): 656658.
  • 40
    Christakis DA, Cowan CA, Garrison MM, Molteni R, Marcuse E, Zerr DM. Variation in inpatients diagnostic testing and management of bronchiolitis. Pediatrics 2005; 115(4): 878884.
  • 41
    Brand PL, Vaessen-Verberne AA. Differences in management of bronchiolitis between hospitals in The Netherlands. Dutch Paediatric Respiratory Society. Eur J Pediatr 2000; 159(5): 343347.
  • 42
    Plint AC, Johnson DW, Wiebe N, Bulloch B, Pusic M, Joubert G, et al. Practice variation among pediatric emergency departments in the treatment of bronchiolitis. Acad Emerg Med 2004; 11(4): 353360.
  • 43
    Gonzalez de Dios J, Ochoa Sangrador C. Study of variability in the management of acute bronchiolitis in Spain in relation to age of patients. National multicenter study (aBREVIADo project). Anales de Pediatria 2010; 72: 418.
  • 44
    Spurling GKP, Fonseka K, Doust J, Del Mar C. Antibiotics for bronchiolitis in children. Cochrane Database of Sytematic Reviews 2007; Issue (1):Art. No.: CD005189.
  • 45
    Gadomski AM, Bhasale AL. Bronchodilators for bronchiolitis. Cochrane Database of Sytematic Reviews 2006; Issue (3):Art. No.: CD001266.
  • 46
    Perrotta C, Ortiz Z, Figuls M. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database of Sytematic Reviews 2007; Issue (1):Art. No.: CD004873.
  • 47
    Blom DJM, Ermers M, Bont L, van Woensel JBM, van Aalderen WMC. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database of Sytematic Reviews 2007; Issue (1):Art. No.: CD004881.
  • 48
    Shah PS, Ohlsson A, Shah JP. Continuous negative extrathoracic pressure or continuous positive airway pressure for acute hypoxemic respiratory failure in children. Cochrane Database of Sytematic Reviews 2008; Issue (1):Art. No.: CD003699.
  • 49
    Liet JM, Ducruet T, Gupta V, Cambonie G. Heliox inhalation therapy for bronchiolitis in infants. Cochrane Database of Sytematic Reviews 2010; Issue (4):Art. No.: CD006915.
  • 50
    Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database of Sytematic Reviews 2008; Issue (4):Art. No.: CD006458.
  • 51
    Fuller HL, Del Mar C. Immunoglobulin treatment for respiratory syncytial virus infection. Cochrane Database of Sytematic Reviews 2006; Issue (4):Art. No.: CD004883.
  • 52
    Rojas-Reyes MX, Granados RC, Charry-Anzola LP. Oxygen therapy for lower respiratory tract infections in children between 3 months and 15 years of age. Cochrane Database of Sytematic Reviews 2009; Issue (1):Art. No.: CD005975.
  • 53
    Rutgeerts P, Lofberg R, Malchow H, Lamers C, Olaison G, Jewell D, et al. A comparison of budesonide with prednisolone for active crohn's disease. N Engl J Med 1994; 331(13): 842845.
  • 54
    Smith M. Therapeutic Choices. 6th ed. Ottawa, Ontario: Canadian Pharmacists Association; 2010.
  • 55
    Black CP. Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir Care 2003; 48(3): 209231.
  • 56
    Hall CB, Powell KR, Schnabel KC, Gala CL, Pincus PH. Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection. J Pediatr 1988; 113(2): 266271.
  • 57
    American Academy of Pediatrics. Diagnosis and management of bronchiolitis. Pediatrics 2006; 118(4): 17741793.
  • 58
    Turner T, Wilkinson F, Harris C, Mazza D, Health for Kids Guideline Development Group. Evidence based guideline for the management of bronchiolitis. Aust Fam Physician 2008; 37(6):(Spec No): 613.
  • 59
    Corneli HM, Zorc JJ, Mahajan P, Shaw KN, Holubkov R, Reeves SD, et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 2007; 357(4): 331339.
  • 60
    Plint AC, Johnson DW, Patel H, Wiebe N, Correll R, Brant R, et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med 2009; 360(20): 20792089.
  • 61
    Gadomski AM, Brower M. Bronchodilators for bronchiolitis (in press). Cochrane Database of Sytematic Reviews 2010.
  • 62
    Hartling L, Bialy L, Vandermeer B, Tjosvold L, Johnson DW, Plint AC, et al. Epinephrine for bronchiolitis (in press). Cochrane Database of Sytematic Reviews 2010.
  • 63
    Fernandes RM, Bialy L, Vandermeer B, Tjosvold L, Plint AC, Patel H, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children (in press). Cochrane Database of Sytematic Reviews 2010.
  • 64
    Bialy L, Smith M, Bourke T, Becker L. The Cochrane Library and bronchiolitis: an umbrella review. Evid-Based Child Health: A Cochrane Rev J 2006; 1(4): 939947.
  • 65
    Review Manager (RevMan) [computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2008.
  • 66
    Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. 2009.
  • 67
    Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al. Grading the strength of a body of evidence when comparing medical interventions. J Clin Epidemiol 2010; 63(5): 513523.
  • 68
    Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924926.
  • 69
    The GRADE Working Group. GRADE handbook for grading quality of evidence and strength of recommendation. Version 3.2 ed. 2009.
  • 70
    Ventre K, Randolph A. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database of Sytematic Reviews 2004; Issue (4):Art. No.: CD000181.
  • 71
    Ventre K, Haroon M, Davison C. Surfactant therapy for bronchiolitis in critically ill infants. Cochrane Database of Sytematic Reviews 2006; Issue (3):Art. No. CD005150.
  • 72
    Chen H, Zhuo Q, Yuan W, Wang J, Wu T. Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age. Cochrane Database of Sytematic Reviews 2008; Issue (1):Art. No.: CD006090.
  • 73
    Everard M, Bara A, Kurian M, N'Diaye T, Ducharme F, Mayowe V. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database of Sytematic Reviews 2005; Issue (3):Art. No.: CD001279.
  • 74
    Chu IW, Mellis C, Lin WY, Enriquez A. Nebulised deoxyribonuclease for viral bronchiolitis in infants (Protocol). Cochrane Database of Sytematic Reviews 2010; Issue (3):Art. No. CD0083.
  • 75
    Umoren R, Odey F, Meremikwu MM. Steam inhalation or humidified oxygen for acute bronchiolitis in children up to three years of age (Protocol). Cochrane Database of Sytematic Reviews 2007; Issue (2):Art. No. CD006435.
  • 76
    Hartling L, Russell K, Patel H, Klassen TP, Liang Y. Epinephrine for bronchiolitis. Cochrane Database of Sytematic Reviews 2004; Issue (1):Art. No.: CD003123.
  • 77
    Patel H, Platt R, Lozano JM. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database of Sytematic Reviews 2008; Issue (1):Art. No.: CD004878.
  • 78
    Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants (in press). Cochrane Database of Sytematic Reviews 2010.
  • 79
    Pearson ES. The percentage limits for the distribution of range in samples from a normal population. Biometrika 1932; 24: 404417.
  • 80
    Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17(1): 112.
  • 81
    Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408412.
  • 82
    Chalmers I, Adams M, Dickersin K, Hetherington J, Tarnow-Mordi W, Meinert C, et al. A cohort study of summary reports of controlled trials. JAMA 1990; 263(10): 14011405.
  • 83
    Bush A. Practice imperfect: treatment for wheezing in preschoolers. N Engl J Med 2009; 360(4): 409410.
  • 84
    Frey U, von Mutius E. The challenge of managing wheezing in infants. N Engl J Med 2009; 360(20): 21302133.
  • 85
    Bjornson CL, Johnson DW. Croup. Lancet 2008; 371(9609): 329339.
  • 86
    Zhang L, Sanguebsche LS. The safety of nebulization with 3 to 5 ml of adrenaline (1:1000) in children: an evidence based review. J Pediatr 2005; 81(3): 193197.
  • 87
    Vandenbroucke JP, Psaty BM. How to combine the best evidence on benefits with the best data about adverse effects. JAMA 2008; 300(20): 24172419.
  • 88
    Dellon EP, Donaldson SH, Johnson R, Davis SD. Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis. Pediatr Pulmonol 2008; 43: 11001106.
  • 89
    Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J 2003; 22: S4044.
  • 90
    Klassen TP. Determining the benefit of bronchodilators in bronchiolitis. When is there enough benefit to warrant adoption into clinical practice? Arch Pediatr Adolescent Med 1996; 150(11): 11201121.
  • 91
    Ioannidis JPA. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ 2009; 181(8): 488493.
  • 92
    Hartling L, Bialy L, Vandermeer B, Tjosvold L, Johnson DW, Plint AC, et al. Comparative effectiveness review of steroids and bronchodilators for the acute care of bronchiolitis. Pediatric Academic Societies 2010 Annual Meeting 2010; 4135. 4.